greeksoup/ stock research
Stock research / United States / MYGN / Documents

Myriad Genetics Inc. documents

Myriad Genetics (MYGN) annual report: the 10-K filed 24 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 14 April 2026; latest 10-Q filed 31 July 2026 for the quarter ended 30 June 2026. Each links to the document on EDGAR, with 6 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
30 July 2026Results press release, exhibit 99 to the 8-K filed 30 July 2026The releaseEDGAR folder
5 May 2026Results press release, exhibit 99 to the 8-K filed 5 May 2026The releaseEDGAR folder
23 February 2026Results press release, exhibit 99 to the 8-K filed 23 February 2026The releaseEDGAR folder
12 January 2026Results press release, exhibit 99 to the 8-K filed 12 January 2026The releaseEDGAR folder
4 November 2025Results press release, exhibit 99 to the 8-K filed 4 November 2025The releaseEDGAR folder
3 November 2025Results press release, exhibit 99 to the 8-K filed 3 November 2025The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
24 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
31 July 202610-Q, period ended 30 June 2026The documentEDGAR folder
6 May 202610-Q, period ended 31 March 2026The documentEDGAR folder
4 November 202510-Q, period ended 30 September 2025The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
14 April 2026DEF 14A, period ended 31 December 2025The documentEDGAR folder

Annual report to shareholders

FiledDocumentOpenWhere
14 April 2026ARS, period ended 31 December 2025The documentEDGAR folder